Literature DB >> 26970563

Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.

Sadamu Kurono1,2, Yuka Kaneko1,2, Nariaki Matsuura3,4, Haruki Oishi1, Shinzaburo Noguchi5, Seung Jin Kim5, Yasuhiro Tamaki6, Takao Aikawa7, Yoshikazu Kotsuma8, Hideo Inaji6, Shuji Matsuura1.   

Abstract

PURPOSE: This research aimed to establish a diagnostic technique for breast cancer using nipple discharge (ND), with the objective of preventive diagnosis. ND has been proposed as a source of secreted proteomes that reflect early pathological changes in the ductal-lobular epithelial microenvironment, and could thus provide breast-specific cancer biomarkers that could be accessed noninvasively as a new clinical diagnostic technique. EXPERIMENTAL
DESIGN: Minute amounts of ND from patients with and without breast cancer (n = 19 and 12, respectively) were collected at the hospital and kept frozen until just before use. They were analyzed using high-pH RP peptide fractionations/low-pH RP 2D nano-LC/ESI-MS/MS. Biomarker candidates were also investigated using Western blot analysis and sandwich ELISA on ND and/or sera.
RESULTS: We found distinct tendencies in protein expression and three candidate breast cancer biomarkers (carbonic anhydrase 2, catalase, and peroxiredoxin-2) whose levels differed significantly between ND specimens from patients with and without breast cancer. CONCLUSIONS AND CLINICAL RELEVANCE: These tendencies in protein expression and markers provide new ways to identify breast cancer patients. Therefore, RP/RP 2D LC/MS/MS analyses of ND and the above three markers are supported as a new breast cancer diagnostic technique.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  2D LC/MS; Biomarkers; Breast cancer; Nipple discharge; Proteomics

Mesh:

Substances:

Year:  2016        PMID: 26970563     DOI: 10.1002/prca.201500016

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  7 in total

1.  Polymeric nanoassemblies for enrichment and detection of peptides and proteins in human breast milk.

Authors:  Bo Zhao; Jingjing Gao; Mahalia A C Serrano; Kathleen F Arcaro; S Thayumanavan; Richard W Vachet
Journal:  Anal Bioanal Chem       Date:  2020-01-10       Impact factor: 4.142

2.  HBFP: a new repository for human body fluid proteome.

Authors:  Dan Shao; Lan Huang; Yan Wang; Xueteng Cui; Yufei Li; Yao Wang; Qin Ma; Wei Du; Juan Cui
Journal:  Database (Oxford)       Date:  2021-10-13       Impact factor: 3.451

Review 3.  Proteomics and its applications in breast cancer.

Authors:  Anca-Narcisa Neagu; Danielle Whitham; Emma Buonanno; Avalon Jenkins; Teodora Alexa-Stratulat; Bogdan Ionel Tamba; Costel C Darie
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

4.  SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma.

Authors:  Yanzhang Luo; Tin Seak Mok; Xiuxian Lin; Wanling Zhang; Yizhi Cui; Jiahui Guo; Xing Chen; Tao Zhang; Tong Wang
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

5.  Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.

Authors:  Sadr-Ul Shaheed; Catherine Tait; Kyriacos Kyriacou; Joanne Mullarkey; Wayne Burrill; Laurence H Patterson; Richard Linforth; Mohamed Salhab; Chris W Sutton
Journal:  Proteomics Clin Appl       Date:  2017-06-26       Impact factor: 3.494

6.  The Prognosis Of Peroxiredoxin Family In Breast Cancer.

Authors:  Gang Wang; Wan-Chao Zhong; Yi-Hui Bi; Si-Yue Tao; Hai Zhu; Hai-Xing Zhu; A-Man Xu
Journal:  Cancer Manag Res       Date:  2019-11-14       Impact factor: 3.989

Review 7.  Breast cancer in the era of integrating "Omics" approaches.

Authors:  Claudia Rossi; Ilaria Cicalini; Maria Concetta Cufaro; Ada Consalvo; Prabin Upadhyaya; Gianluca Sala; Ivana Antonucci; Piero Del Boccio; Liborio Stuppia; Vincenzo De Laurenzi
Journal:  Oncogenesis       Date:  2022-04-14       Impact factor: 6.524

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.